ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy (Q46792525)
Jump to navigation
Jump to search
scientific article published in January 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy |
scientific article published in January 1998 |
Statements
1 reference
ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy (English)
1 reference
R Metzger
1 reference
C G Leichman
1 reference
K D Danenberg
1 reference
P V Danenberg
1 reference
H J Lenz
1 reference
K Hayashi
1 reference
S Groshen
1 reference
D Salonga
1 reference
H Cohen
1 reference
L Laine
1 reference
P Crookes
1 reference
H Silberman
1 reference
J Baranda
1 reference
B Konda
1 reference
L Leichman
1 reference
1 January 1998
1 reference
16
1 reference
1
1 reference
309-316
1 reference